InsiderClue
Insiders · Profile

Thackray Helen M.

Chief R&D Officer at BIOCRYST PHARMACEUTICALS · SVP Clinical Development, CMO at CRESCENT BIOPHARMA. Filing since 1 Jul 2016. CIK 0001589725

BCRX BIOCRYST PHARMACEUTICALS INC Chief R&D Officer · 4 trades CBIO CRESCENT BIOPHARMA, INC. SVP Clinical Development, CMO · 9 trades
Company
Date
Role
Action
Shares
Amount
Of holding
BCRX BIOCRYST PHARMACEUTICALS INC
14 May 2024
Chief R&D Officer
Bought
30,000
$175.80K
12.4%
BCRX BIOCRYST PHARMACEUTICALS INC
3 Apr 2023
Chief R&D Officer
Sold on a plan
7,000
$58.03K
3.3%
BCRX BIOCRYST PHARMACEUTICALS INC
15 Dec 2022
Chief R&D Officer
Sold, plan not stated
3,125
$34.03K
2.3%
BCRX BIOCRYST PHARMACEUTICALS INC
1 Apr 2022
Chief R&D Officer
Sold, plan not stated
7,600
$123.12K
5.3%
CBIO CRESCENT BIOPHARMA, INC.
8 Dec 2017
SVP Clinical Development, CMO
Sold, plan not stated
2,000
$30.02K
1.3%
CBIO CRESCENT BIOPHARMA, INC.
18 Sep 2017
SVP Clinical Development, CMO
Sold, plan not stated
2,000
$26.00K
1.3%
CBIO CRESCENT BIOPHARMA, INC.
25 May 2017
SVP Clinical Development, CMO
Sold, plan not stated
2,000
$31.14K
1.3%
CBIO CRESCENT BIOPHARMA, INC.
19 May 2017
SVP Clinical Development, CMO
Sold, plan not stated
2,000
$24.28K
1.3%
CBIO CRESCENT BIOPHARMA, INC.
3 Oct 2016
VP Clinical Development, CMO
Sold, plan not stated
4,000
$28.00K
2.5%
CBIO CRESCENT BIOPHARMA, INC.
20 Jul 2016
VP Clinical Development, CMO
Sold, plan not stated
2,000
$16.00K
1.2%
CBIO CRESCENT BIOPHARMA, INC.
6 Jul 2016
VP Clinical Development, CMO
Sold, plan not stated
6,796
$45.40K
4.0%
CBIO CRESCENT BIOPHARMA, INC.
5 Jul 2016
VP Clinical Development, CMO
Sold, plan not stated
10,136
$71.05K
5.6%
CBIO CRESCENT BIOPHARMA, INC.
1 Jul 2016
VP Clinical Development, CMO
Sold, plan not stated
5,068
$37.50K
2.7%
13 decisions on file.